BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11305006)

  • 41. Using imipenem and cilastatin during continuous renal replacement therapy.
    Cotton A; Franklin BD; Brett S; Holmes A
    Pharm World Sci; 2005 Oct; 27(5):371-5. PubMed ID: 16341743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical efficacy of imipenem/cilastatin sodium for respiratory infections in patients with lung cancer].
    Yoshida M; Watanabe K; Tanaka H; Senju S; Ishibashi T; Takamoto M; Oizumi K; Kondo Y; Shigematsu H; Ohno T; Ichikawa Y; Hara N; Mitsuyama T; Nakanishi Y; Yamada H; Kuroki S; Motohiro A; Ueda H; Kusano T; Hiratsuka M; Nikaido Y; Kido M; Miyahara T; Ninomiya K; Naoe H
    Jpn J Antibiot; 1997 Jan; 50(1):22-38. PubMed ID: 9059911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
    Urabe A; Fujita A; Aoki K; Koike M; Kitamura K; Ohbayashi Y; Oshimi K; Wakabayashi Y; Kuraishi Y; Kurihara I; Togawa A; Hoshino S; Ozawa K; Hotta T; Higashihara M; Nagoshi H; Hirai H; Omine M; Asano S; Nishimura M; Suzuki K; Bessho M; Mizoguchi H; Furusawa S; Nonaka Y; Takaku F
    Jpn J Antibiot; 2000 Feb; 53(2):61-74. PubMed ID: 10786314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of successful medical treatment for necrotizing fasciitis of the chest wall with diabetic nephropathy].
    Kobayashi Y; Yasuba H; Yamashita K; Kita H; Chiba W; Hitomi S
    Nihon Kokyuki Gakkai Zasshi; 2005 Mar; 43(3):160-4. PubMed ID: 15801285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doripenem: excess mortality.
    Prescrire Int; 2012 Sep; 21(130):214. PubMed ID: 23016255
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic evaluation of combination therapy using C-425, human native immunoglobulin liquid preparation for i.v. administration, with antibiotics in severe infections in the field of internal medicine].
    Kitamura K; Takaku F; Miyazaki T; Wakui A; Mizoguchi H; Uchino H; Masaoka T; Nagai K; Niho Y
    Kansenshogaku Zasshi; 1990 Jan; 64(1):19-33. PubMed ID: 2186159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic evaluation of combination therapy using C-425, human native immunoglobulin liquid preparation for i.v. administration, and antibiotics in severe and/or refractory infections in pediatrics].
    Nishimura T; Fujii R; Abe T; Meguro H; Hiruma F; Hori M; Tatsuzawa O; Maekawa K; Wada N; Kubo M
    Kansenshogaku Zasshi; 1990 Jan; 64(1):34-53. PubMed ID: 2186160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Why meropenem and not imipenem?].
    Fuursted K; Møller JK
    Ugeskr Laeger; 2003 Mar; 165(10):1046-7; author reply 1047. PubMed ID: 12645417
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapeutic evaluation of combination therapy using C-425, human native immunoglobulin liquid preparation for i.v. administration, with antibiotics in severe infections in the field of surgery].
    Mishima Y; Inoue T; Hayasaka H; Totsuka M; Ebata T; Motoki R; Inoue H; Endo Y; Tamakuma S; Imai J
    Kansenshogaku Zasshi; 1990 Jan; 64(1):54-64. PubMed ID: 2186161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapeutic evaluation of combination therapy with IG-100, pH4-treated human immunoglobulin preparation for i.v. administration, and antibiotics against severe infections. The Society for Clinical Investigation on IG-100].
    Matsumoto K; Masaoka T; Nakamura T; Shimada K; Urushizaki I; Kogo Y; Saito A; Tomizawa M; Nakayana I; Mikuni C
    Kansenshogaku Zasshi; 1984 Oct; 58(10):1001-24. PubMed ID: 6442315
    [No Abstract]   [Full Text] [Related]  

  • 51. Benefits, efficacy, cost-effectiveness and infectious complications in transplant patients desensitized with intravenous immunoglobulin and anti-CD20 therapy.
    Vo AA; Jordan SC
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):48-51. PubMed ID: 25546759
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical evaluation of SM-4300 and antibiotics combinations against severe bacterial infections in surgery].
    Yura J; Shinagawa N; Ishikawa S; Nakamura A; Yoshimi O; Fukumoto I
    Jpn J Antibiot; 1985 Sep; 38(9):2622-9. PubMed ID: 4079027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapeutic effect of a new human immunoglobulin SM-4300 on the severe infections in surgical patients].
    Nakayama I; Kawaguchi H; Yamaji E; Akieda Y; Itokawa K
    Jpn J Antibiot; 1985 Sep; 38(9):2617-21. PubMed ID: 3935829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Combination with immunoglobulin and antibiotics for the treatment of infectious diseases].
    Sasada M
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():261-5. PubMed ID: 12717981
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapeutic evaluation of combination therapy using C-425 and antibiotics in severe bacterial infections--a double blind group comparative study. The C-425 Research Group for Infectious Comparative Study].
    Katayama N; Akatsuka Y; Ikeda Y; Ichihara M; Ohno R; Okumura M; Ono Y; Ohara K; Kageyama S; Kato Y
    Kansenshogaku Zasshi; 1990 Feb; 64(2):149-61. PubMed ID: 2187036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Locally-administered antibiotics in wounds in a limb.
    Branstetter JG; Jackson SR; Haggard WO; Richelsoph KC; Wenke JC
    J Bone Joint Surg Br; 2009 Aug; 91(8):1106-9. PubMed ID: 19651846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infection with Fusarium species in two children with neuroblastoma.
    Viscoli C; Castagnola E; Moroni C; Garaventa A; Manno G; Savioli C
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):773-6. PubMed ID: 2148147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evidence-based therapeutic guidelines for severe acute pancreatitis].
    Takeda K
    Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):24-8. PubMed ID: 14968570
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic effects of SM-4300 and antibiotics combination against severe bacterial infections].
    Nakamura T; Yoneda M; Irie T; Kumasaka Y; Yoshida S; Ohmi T; Okamoto K; Takebe K
    Jpn J Antibiot; 1985 Sep; 38(9):2489-95. PubMed ID: 4079015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous regional infusion of imipenem for antimicrobial chemoprophylaxis in orthopaedic surgery.
    Vrettou I; Voyagis GS
    Eur J Anaesthesiol; 1998 Nov; 15(6):801-2. PubMed ID: 9884874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.